FAC Explorer

Finding 1239319 (2025-001)

Material Weakness Repeat Finding
Requirement
ELN
Questioned Costs
-
Year
2025
Accepted
2026-09-30
Audit: 414174
Organization: Atrium Health, Inc. (NC)
Auditor: ERNST AND YOUNG LLP

AI Summary

  • Core Issue: Internal controls for the Student Financial Assistance IT systems at Atrium Health CMHA were not evaluated for accuracy and completeness in fiscal year 2025.
  • Impacted Requirements: This finding violates Section 200.303 of Title 2 U.S. Code, which mandates effective internal controls over federal awards.
  • Recommended Follow-Up: Atrium Health CMHA should establish and test internal controls or implement compensating measures to ensure data integrity in the IT systems.

Finding Text

Finding 2025-001: Internal controls within the Student Financial Assistance (SFA) IT Systems | Identification of the Federal Program: Federal Agency: United States Department of Education. Federal Cluster: Student Financial Assistance Cluster. Assistance Listing No.: 84.268 Federal Direct Student Loans (Direct Loans) and 84.063 Federal Pell Grant Program. Award Periods: July 1, 2024 through June 30, 2025; July 1, 2025 through June 30, 2026. Section III – Federal Award Findings and Questioned Costs (continued). Criteria or Specific Requirement (Including Statutory, Regulatory or Other Citation): Section 200.303 of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) states the following regarding internal control: “The non-Federal entity must: (a) Establish, document, and maintain effective internal control over the Federal award that provides reasonable assurance that the recipient or subrecipient is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should align with the guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control-Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” Condition: Atrium Health CMHA has two primary student financial assistance (SFA) information technology (IT) systems and related applications that are used to process student financial assistance eligibility and disbursements as well as various other special tests and provisions required by the United States Department of Education. Internal controls over the accuracy and completeness of the data and applications within the SFA IT systems at Atrium Health CMHA were not evaluated for fiscal year 2025. Cause: Internal controls over the accuracy and completeness of the data and applications within the SFA IT systems at Atrium Health CMHA were not evaluated for fiscal year 2025. Effect or Potential Effect: The data used within the IT systems and applications may not be complete or accurate or the applications may not function as intended. Section III – Federal Award Findings and Questioned Costs (continued). Questioned Costs: None. Context: Total federal expenditures for the Student Financial Assistance Cluster recorded on the Schedule of Expenditures of Federal Awards (Schedule) totaled $3,348,141 for the year ended December 31, 2025. Identification as a Repeat Finding, if Applicable: This finding is a repeat finding of 2024-001 from the prior year. Recommendation: Atrium Health CMHA should implement internal controls to ensure the IT systems are tested or implement compensating controls to ensure the data is accurate and complete. Views of Responsible Officials: Management agrees with the finding and has developed a plan to correct the finding.

Corrective Action Plan

Finding 2025-001: Internal controls within the Student Financial Assistance (SFA) IT Systems | Name of Contact Person: Jared Smith, Dean of Student Affairs and Enrollment Management & Amy Brown, Director of Financial Aid | Corrective Action Plan: Carolinas College is implementing PowerFAIDS as its new student financial aid management system, with deployment anticipated in August 2027. The new platform is expected to address limitations in the current Jenzabar Financial Aid system related to reporting capabilities, disbursement verification, and record retention. Until implementation is complete, management will utilize supplemental manual procedures, including maintaining supporting documentation and screenshots, to ensure adequate documentation of eligibility determinations, reporting, and disbursement activities. | Proposed Completion Date: Management expects interim remediation through enhanced manual recordkeeping procedures by December 31, 2026. Following the implementation of PowerFAIDS in August of 2027, a full remediation is expected to be completed by December 31, 2027. Due to the academic-year operating cycle, the College is unable to transition financial aid systems during the middle of an active award year, making a phased implementation approach necessary.

Categories

Student Financial Aid Matching / Level of Effort / Earmarking Special Tests & Provisions Subrecipient Monitoring Allowable Costs / Cost Principles Eligibility Reporting

Other Findings in this Audit

  • 1239318 2025-001
    Material Weakness Repeat
  • 1239320 2025-002
    Material Weakness Repeat
  • 1239321 2025-002
    Material Weakness Repeat
  • 1239322 2025-003
    Material Weakness Repeat
  • 1239323 2025-003
    Material Weakness Repeat
  • 1239324 2025-004
    Material Weakness Repeat
  • 1239325 2025-004
    Material Weakness Repeat
  • 1239326 2025-005
    Material Weakness Repeat
  • 1239327 2025-005
    Material Weakness Repeat
  • 1239328 2025-006
    Material Weakness Repeat
  • 1239329 2025-006
    Material Weakness Repeat
  • 1239330 2025-006
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
84.268 FEDERAL DIRECT STUDENT LOANS $2.14M
84.063 FEDERAL PELL GRANT PROGRAM $1.21M
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $194,284
16.575 CRIME VICTIM ASSISTANCE $159,191
97.036 DISASTER GRANTS - PUBLIC ASSISTANCE (PRESIDENTIALLY DECLARED DISASTERS) $134,535
93.788 OPIOID STR $115,998
93.173 RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS $115,617
16.753 CONGRESSIONALLY RECOMMENDED AWARDS $66,902
93.RD A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection $37,305
93.RD AWD00002326 NCI A022104 CLT $34,031
93.145 HIV-RELATED TRAINING AND TECHNICAL ASSISTANCE $30,925
93.078 STRENGTHENING EMERGENCY CARE DELIVERY IN THE UNITED STATES HEALTHCARE SYSTEM THROUGH HEALTH INFORMATION AND PROMOTION $28,732
93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH $21,872
93.RD Impact of the COVID-19 pandemic, SARS-CoV-2 $17,941
93.RD AWD00002145 Kaplan CMHA ASCT2031 $16,598
93.RD S2308_CLT_AWD00002717 $13,503
93.837 CARDIOVASCULAR DISEASES RESEARCH $12,344
93.399 CANCER CONTROL $11,904
93.RD SWOG $11,856
93.958 BLOCK GRANTS FOR COMMUNITY MENTAL HEALTH SERVICES $11,563
93.RD ALLIANCE for Clinical Trials in Oncology $11,436
14.251 ECONOMIC DEVELOPMENT INITIATIVE, COMMUNITY PROJECT FUNDING, AND MISCELLANEOUS GRANTS $8,595
93.RD NMDP Adults Registry $7,969
93.RD CIBMTR Registry $7,783
93.RD NMTRC 014 $7,704
93.RD Bhutani_SWOG_S2005_CLT_AWD00002919 $6,560
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $5,967
93.RD Rider TransIT $5,404
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $5,196
93.RD A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors $4,862
93.RD NMTRC012 $4,744
93.073 BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES - PREVENTION AND SURVEILLANCE $4,010
93.RD AREN1921 $3,836
93.RD A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First $3,332
93.RD A222004 $3,266
93.RD AWD00002605 Kaplan NCI COG ANBL2131 $2,827
93.395 CANCER TREATMENT RESEARCH $2,783
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $2,566
93.110 SPECIAL PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $2,389
93.866 AGING RESEARCH $1,911
12.300 BASIC AND APPLIED SCIENTIFIC RESEARCH $1,716
93.RD Sickle Cell #1507 $1,035
93.262 OCCUPATIONAL SAFETY AND HEALTH PROGRAM $849
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $783
93.RD National Experimental Therapeutics Consortium $724
93.RD ECOG-ACRIN - EA1141 $685
93.RD ANBL1531 $630
93.RD LCCC1317 $621
93.RD APEC1621_COG MATCH $547
93.RD MYELOMATCH_AWD00002888 $502
93.RD ARST2031 $500
93.RD ACNS1931 $434
93.RD Knight_Thomas_NCI_MM1YA-CTG01-CLT $417
93.137 COMMUNITY PROGRAMS TO IMPROVE MINORITY HEALTH $380
93.667 SOCIAL SERVICES BLOCK GRANT $228
93.RD ALTE1631 $210
93.RD C11173_BMT CTN2207_CLT $206
93.RD AHOD1331 $144
93.RD AGCT1532 $129
93.RD ARST2032 $129
93.RD A021806 $116
93.RD MMRC-089 $93
93.839 BLOOD DISEASES AND RESOURCES RESEARCH $43
93.360 BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA), BIODEFENSE MEDICAL COUNTERMEASURE DEVELOPMENT $-4,155
93.310 TRANS-NIH RESEARCH SUPPORT $-13,543
93.865 CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH $-53,508